Buprenorphine Treatment Centers in Montana

For methadone and buprenorphine, continued opioid use during induction is common and expected; the medication itself helps stop use. For naltrexone, however, you must complete a 7–14 day opioid-free period first. Your Montana clinician will tailor the induction based on your medication.

For most Montana residents, Montana Medicaid (HELP Plan) is the lowest-cost option — co-pays are usually $0–$3. Without Medicaid, federally qualified health centers with sliding-scale fees are next cheapest, followed by State Opioid Response–funded clinics.

Yes. Pregnancy-related Montana Medicaid (HELP Plan) coverage includes MAT with no copays and priority access to Montana perinatal-MAT programs. Many Montana Medicaid (HELP Plan) plans also extend coverage for 12 months postpartum to protect the mother–infant dyad.

Yes. Parity law requires equal coverage for the medication and counseling components of MAT. Counseling copays often match mental-health visit copays (typically $20–$50 for commercial plans in Montana). Providers bill counseling and medication separately.

Montana applies state-specific licensure review for new OTPs; some states also require a certificate-of-need demonstrating unmet demand. Existing buprenorphine prescribers do not face these caps — only methadone OTPs are subject to location-specific licensure review.

Early in treatment, visits are weekly — sometimes daily for methadone induction. After stabilization, buprenorphine patients typically visit monthly, and methadone patients may qualify for take-home doses reducing visits to bi-weekly or monthly. Naltrexone injections are monthly.

No. Montana employers have no right to require MAT disclosure. ADA protections and 42 CFR Part 2 confidentiality prevent providers from disclosing MAT status to employers. If you need FMLA for appointments, your HR can verify medical leave without knowing the diagnosis.

Your first visit includes a medical and psychiatric history, physical exam, urine drug screen, basic lab work, and an intake assessment with a counselor. If eligible, you’ll receive your first medication dose or prescription and a follow-up schedule before leaving.

Constipation is one of the most common and persistent buprenorphine side effects. Daily fluids, fiber, stool softeners, and an over-the-counter laxative like polyethylene glycol are first-line. If severe, your Montana clinician may prescribe a peripherally acting opioid-receptor antagonist.

Yes. Starting MAT during pregnancy is strongly recommended for patients with OUD. Montana perinatal-addiction programs offer priority same-day access; OB-MAT coordinated care improves maternal and infant outcomes dramatically compared to untreated OUD.

Sessions cover craving management, relapse-prevention skills, coping strategies, relationship issues, trauma processing if relevant, and goal setting for recovery. The counselor and client collaborate on a written treatment plan that is updated every 30–90 days in Montana.

If you use insurance, the insurer sees billed services (including MAT). They cannot share that with your employer or family. If you strongly value privacy from insurance, self-pay is the only fully insulated option.